In a significant interim reprieve for hepatologist Dr. Cyriac Abby Philips, widely known as TheLiverDoc, the Kerala High Court has paused his personal appearance before a magistrate in a criminal defamation case sparked by his warnings on herbal medicines and liver injury risks.
Justice Jobin Sebastian, hearing the matter on Tuesday, ordered that the summons issued by the trial court would remain deferred until the High Court takes up the case again on May 22, offering temporary relief as Philips challenges the proceedings against him.
The dispute stems from a complaint filed by an Ayurveda manufacturer, which accused the doctor of damaging its reputation through a social media post linked to a patient suffering acute liver failure allegedly after consuming traditional herbal medicine. The post, shared in 2024, questioned the safety of certain products, criticized what Philips described as unverified alternative medicine claims, and included images of products manufactured by the complainant.
The company argued the post suggested its products were responsible for the patient’s condition, hurting its credibility and goodwill. A magistrate had taken cognizance of the complaint under criminal defamation provisions and summoned Philips, ruling that his defense based on statutory exceptions could be examined only during trial.
Philips pushed back in the High Court, framing the prosecution as more than a personal legal battle — casting it as a test of whether scientific criticism and public health warnings can invite criminal action.
His petition argued the post was rooted in documented clinical findings involving herb-induced liver injury, supported by medical records and diagnostic evidence. It maintained the statements were made in good faith, driven by professional responsibility and concern for public safety, rather than any intent to defame.
A key plank of his challenge is that criticism of a product, even sharply worded, should not automatically translate into criminal defamation against its manufacturer. His legal team also invoked protections available for statements made for public good and in good faith, contending those safeguards should have been weighed before criminal proceedings were set in motion.
The High Court, while not entering the merits of the dispute at this stage, granted interim protection after hearing submissions, keeping the matter alive for fuller examination next month.
The case now sits at the intersection of two combustible questions — reputation versus scientific scrutiny, and whether medical dissent on public platforms can be prosecuted as defamation. For the moment, the court has pressed pause.
